These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 7437709)

  • 1. Semi-quantitative analysis of the bone scan in acromegaly: correlation with human growth hormone values.
    Fogelman I; Hay ID; Citrin DL; Beastall GH; Turner JG; Bessent RG
    Br J Radiol; 1980 Sep; 53(633):874-7. PubMed ID: 7437709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Value of growth hormone dynamics and somatomedin C (insulin-like growth factor I) levels in predicting the long-term benefit after transsphenoidal surgery for acromegaly.
    Arafah BM; Rosenzweig JL; Fenstermaker R; Salazar R; McBride CE; Selman W
    J Lab Clin Med; 1987 Mar; 109(3):346-54. PubMed ID: 3102658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spinal and peripheral bone mineral densities in acromegaly: the effects of excess growth hormone and hypogonadism.
    Diamond T; Nery L; Posen S
    Ann Intern Med; 1989 Oct; 111(7):567-73. PubMed ID: 2774387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The nature of the metabolic bone disorder in acromegaly.
    Riggs BL; Randall RV; Wahner HW; Jowsey J; Kelly PJ; Singh M
    J Clin Endocrinol Metab; 1972 Jun; 34(6):911-8. PubMed ID: 5020422
    [No Abstract]   [Full Text] [Related]  

  • 5. Growth hormone isoforms in acromegalic patients before and after treatment with octreotide LAR.
    Lima GA; Wu Z; Silva CM; Barbosa FR; Dias JS; Schrank Y; Strasburger CJ; Gadelha MR
    Growth Horm IGF Res; 2010 Apr; 20(2):87-92. PubMed ID: 19884028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum concentrations of somatomedins and growth hormone in relation to bone metabolism in acromegaly and thyroid dysfunction.
    Bijlsma JW; Duursma SA
    Clin Exp Rheumatol; 1986; 4(2):105-10. PubMed ID: 3731567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of growth hormone and other hormones on trabecular bone structure in acromegaly].
    Zák J; Kapitola J; Povýsil C; Haas T
    Sb Lek; 1999; 100(3):223-33. PubMed ID: 11221470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stable reduction of plasma growth hormone (hGH) levels during chronic administration of 2-Br-alpha-ergocryptine (CB-154) in acromegalic patients.
    Chiodini PG; Liuzzi A; Botalla L; Oppizzi G; Müller EE; Silvestrini F
    J Clin Endocrinol Metab; 1975 Apr; 40(4):705-8. PubMed ID: 1127079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone scintigraphy in acromegaly. Preliminary report on 10 cases.
    Pereţianu D; Grigorie D; Popescu F; Zaharescu J
    Endocrinologie; 1990; 28(3-4):199-205. PubMed ID: 2129487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The place of insulin-like growth factor I in the diagnosis of acromegaly].
    Dohán O; Góth M; Szabolcs I; Kovács L; Kovács Z; Szilágyi G
    Orv Hetil; 1993 Oct; 134(42):2301-3. PubMed ID: 8233444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Parameters of human growth hormone (hGH) levels reflecting the activity of acromegaly].
    Jin ZM; Shi YF; Deng JY
    Zhonghua Nei Ke Za Zhi; 1987 May; 26(5):269-72, 318. PubMed ID: 3652832
    [No Abstract]   [Full Text] [Related]  

  • 12. Diagnosis of acromegaly on cranial computed tomography.
    Barmeir EP; Lipschitz S; Dubowitz B; Kalk WJ
    Isr J Med Sci; 1982 Aug; 18(8):830-4. PubMed ID: 7118530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radioimmunoassayable serum somatomedin B in normal subjects and in patients with acromegaly and pituitary dwarfism: effects of human growth hormone therapy.
    Wajchenberg BL; Liberman B; Gomes EN; Pieroni RR
    Horm Metab Res; 1980 Oct; 12(10):516-9. PubMed ID: 7439876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical assessment of bone formation and resorption in acromegaly.
    Ezzat S; Melmed S; Endres D; Eyre DR; Singer FR
    J Clin Endocrinol Metab; 1993 Jun; 76(6):1452-7. PubMed ID: 8501150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the paradoxical growth hormone inhibitory effect of galanin in acromegaly.
    Giustina A; Bresciani E; Bussi AR; Bollati A; Bonfanti C; Bugari G; Chiesa L; Giustina G
    J Clin Endocrinol Metab; 1995 Apr; 80(4):1333-40. PubMed ID: 7536207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suprasellar extension of tumor associated with increased cerebrospinal fluid activity of growth hormone.
    Hanson EJ; Miller RH; Randall RV
    Mayo Clin Proc; 1976 Jul; 51(7):412-6. PubMed ID: 933557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth hormone (GH) and prolactin responses to repetitive administration of GH-releasing hormone in acromegaly.
    Losa M; Schopohl J; König A; Müller OA; von Werder K
    J Clin Endocrinol Metab; 1986 Aug; 63(2):475-80. PubMed ID: 3088026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Interrelation between static parameters of trabecular bones in acromegaly, the STH levels and the duration of the condition. Histomorphometric study].
    Zák J; Povýsil C; Pacovský V; Marek J
    Cas Lek Cesk; 1990 Oct; 129(40):1252-5. PubMed ID: 2257568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Radioreceptorassay for human growth hormone in serum].
    Deng JY
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1989 Oct; 11(5):326-30. PubMed ID: 2534611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the sensitivity of growth hormone secretion to somatostatin in vivo and in vitro in acromegaly.
    Kelijman M; Williams TC; Downs TR; Frohman LA
    J Clin Endocrinol Metab; 1988 Nov; 67(5):958-63. PubMed ID: 2903171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.